Few companies had a year as bumpy as 23andMe had in 2024, with the company settling a lawsuit related to a data breach and announcing a round of layoffs. Amid that turmoil, many of the popular ...

Me faces uncertainty amid acquisition talks and board resignations, and users are worried about their data. Here's what the ...

Me, once valued at $6 billion, is now a penny stock. Layoffs, data breaches, and resignations led to its downfall. How did it ...

23andMe ME1.34%increase; green up pointing triangle rejected its chief executive’s proposal to buy back the company at 41 cents a share as the struggling company explores strategic alternatives ...

23andMe CEO Anne Wojcicki and New Mountain Capital have submitted a proposal to take the embattled genetic testing company private, according to a Friday filing with the U.S. Securities and ...

The genetic testing company 23andMe has agreed to pay $30 million to American plaintiffs to settle a lawsuit over a data breach last year that specifically targeted customers of Ashkenazi Jewish ...

Anna Wojcicki, the CEO of DNA testing app 23andMe that was sold for $6billion, is trying to buy the company back for just $75million. The troubled company was worth billions six years ago but now ...

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company, after months of speculation about its future. The company's board has formed a ...

When evaluating 23andMe's stock performance and future outlook, investors should consider short-term market trends and long-term growth potential. This analysis will dive into recent stock metrics ...

23andMe Holding Co. operates as a consumer genetics testing company in the United States, the United Kingdom, Canada, and internationally. The company operates in two segments, Consumer and ...